Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Sources Sought opportunity from Department Of Health And Human Services was posted on July 24, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Whole-Slide Imaging (WSI) Scanner System

Closed
CDRH-2026-135447Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The U.S. Food and Drug Administration is seeking information from potential vendors to identify capable sources for a single Whole-Slide Imaging Scanner System that delivers automated bright-field whole-slide imaging, including image acquisition, stitching, viewing software, and data storage with all necessary accessories. The system must meet specified minimum technical requirements outlined in the Sources Sought Notice, and responses are being collected to inform future procurement decisions rather than to award a contract at this stage. The solicitation number is CDRH-2026-135447, and submissions are due by August 7, 2026, at 4:00 PM EDT. The procurement is managed by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with the primary point of contact being Erika Crawford, reachable via email or phone. The contract opportunity is categorized under NAICS code 334516 and is not subject to any small business or socioeconomic set-asides. Responses must be submitted through the designated SAM.gov portal, and the anticipated place of performance is in Silver Spring, Maryland, with the agency office located in Rockville, Maryland. This initiative supports the FDA’s efforts to enhance digital pathology capabilities through advanced imaging technology.

General Info

FDA seeks vendors for whole-slide imaging scanner system by August 7, 2026, for digital pathology enhancement.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

334516 - Analytical Laboratory Instrument ManufacturingView NAICS

Place of Performance

Silver Spring, MD, 20993, USA

Set-Aside

NONE

Documents

(1)

Sources Sought Notice for Whole-Slide Imaging Scanner System CDRH-2026-135447

PDFsources-sought

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA

Full Description

Show more

The U.S. Food and Drug Administration (FDA) is conducting market research to identify capable sources for one (1) new Whole-Slide Imaging (WSI) Scanner System. The system shall provide automated bright-field whole-slide imaging, image acquisition, image stitching, viewing software, data storage, and associated accessories meeting the minimum technical requirements identified in the Sources Sought Notice. This notice is issued for market research purposes only and is not a solicitation for offers.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research is seeking a firm-fixed-price purchase order for human induced pluripotent stem cell-derived hindbrain organoid functional assay services. The contract involves the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to evaluate electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. This is a commercial service acquisition under FAR Part 12, intended as a sole-source award to OrganoTherapeutics SARL based on market research identifying them as the only source capable of meeting the full requirement. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS